image
Anavex Life Sciences Corp. AVXL
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 7.445
-7.29 %
$ 631 M
Market Cap
-14.6
P/E
BALANCE SHEET
154 M ASSETS
1.10%
Growth Rates
1Year 1.10%
3Years 64.72%
5Years 44.65%
7Years 48.93%
10Years 81.71%
12.5 M LIABILITIES
22.72%
Growth Rates
1Year 22.72%
3Years 19.71%
5Years 26.40%
7Years 21.59%
10Years 15.94%
142 M EQUITY
-0.45%
Growth Rates
1Year -0.45%
3Years 73.34%
5Years 47.25%
7Years 56.00%
10Years 50.49%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Anavex Life Sciences Corp.
image
Current Assets 154 M
Cash & Short-Term Investments 151 M
Receivables 2.71 M
Other Current Assets 653 K
Non-Current Assets 0
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 0
Current Liabilities 12.5 M
Accounts Payable 4.32 M
Short-Term Debt 0
Other Current Liabilities 8.21 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Sep-2023 Sep-2022 Sep-2021 Sep-2020 Sep-2019 Sep-2018 Sep-2017 Sep-2016 Sep-2015 Sep-2014 Sep-2013 Sep-2012 Sep-2011 Sep-2010 Sep-2009 Sep-2008 Sep-2007 Sep-2006 Sep-2005 Sep-2004
ASSETS
Cash & Cash Equivalents 151.0 149.2 152.1 29.2 22.2 22.9 27.4 9.2 15.3 7.3 0.3 11.4 K 0.1 0.3 0.4 6.36 K 25 12.3 K 977 28.1 K
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 2.7 3.2 9.1 4.8 2.6 1.9 9.75 K 79.3 K 76.8 K 0 0 0 809 37.8 K 0 0 0 0 0 0
Inventory 0 0 16.4 K 0 (2.6) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0.7 0.4 0.4 0.4 0.5 1.3 0.3 0.2 0.1 89.1 K 48.4 K 1.22 K 65.1 K 23.3 K 56 K 0 0 220 0 0
Total Current Assets 154.4 152.7 161.6 34.5 25.3 24.3 27.8 9.4 15.5 7.4 0.4 12.6 K 0.2 0.3 0.4 6.36 K 25 12.5 K 977 28.1 K
PP&E 0 0 0 0 0 0 0 0 1.25 K 2.25 K 0 576 2.43 K 4.09 K 1.69 K 862 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0 16.4 K 0 0 52.4 K 52.4 K 52.4 K 0 0 0 0 0 0 0 0 0 0 0 0
Other Assets 0 3 546.7 16.4 K 5.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 154.4 152.7 161.6 34.5 25.3 24.4 27.8 9.5 15.5 7.4 0.4 13.2 K 0.2 0.3 0.4 7.22 K 25 12.5 K 977 28.1 K
LIABILITIES
Accounts Payable 4.3 3.8 4.7 4.0 3.5 3.0 3.6 3.1 2.5 1.2 1.7 2.46 K 0.4 0.8 1.6 0.7 0.5 8.01 K 17.1 K 0
Short Term Debt 0 0 0 0 0 0 0 0 85.2 K 0.2 0.2 0.3 0.9 2.5 2.5 1.6 0 20 K 0 0
Other Current Liabilities 8.2 6.4 5.6 3.3 1.5 0.9 0 14.8 0.1 28.2 K 30.4 K 2.6 67.5 K 0 0 0 0 0 9.94 K 2.5 K
Total Current Liabilities 12.5 10.2 10.8 7.3 5.0 3.9 3.6 3.2 2.7 1.4 2.0 2.9 1.3 3.3 4.1 2.3 0.5 28 K 27 K 2.5 K
Long Term Debt 0 0 0 0 0 0 0 0 332 5.7 0 0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Liabilities 12.5 10.2 10.8 7.3 5.0 3.9 3.6 3.2 2.7 7.2 2.9 2.9 1.3 3.3 4.3 2.3 0.5 28 K 27 K 2.5 K
EQUITY
Common Stock 82 K 77.9 K 75.9 K 62 K 52.7 K 45.9 K 43.3 K 36.2 K 32 K 47.2 K 37.2 K 30.2 K 26.6 K 23.5 K 20.7 K 20 K 19.5 K 19.2 K 3.2 K 2 K
Retained Earnings (293.1) (245.6) (197.6) (159.7) (133.4) (108.9) (91.5) (78.0) (63.3) (52.6) (41.2) (37.5) (29.2) (21.9) (12.6) (7.1) (1.7) (0.1) (0.1) 14.4 K
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 0 0 1.76 K 768 5.63 K 5.06 K 3.2 K 1.54 K 630 0.1 0 0 0 0
Total Equity 141.9 142.5 150.8 27.2 20.3 20.5 24.3 6.3 12.8 0.2 (2.5) (2.9) (1.1) (3.0) (3.9) (2.3) (0.5) 15.5 K 26 K 25.6 K
Total Liabilities and Equity 154.4 152.7 161.6 34.5 25.3 24.4 27.8 9.5 15.5 7.4 0.4 13.2 K 0.2 0.3 0.4 7.22 K 25 12.5 K 977 28.1 K
SHARES OUTSTANDING
Common Shares Outstanding 79.8 76.9 69.8 58.2 48.9 44.7 40.8 35.2 18.6 9.8 8.0 7.0 6.3 5.4 5.1 4.9 4.8 4.8 4.3 1.9